Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...
Jan 12 (Reuters) - Gilead Sciences' (GILD.O), opens new tab new HIV prevention drug has been added to CVS Health's (CVS.N), opens new tab commercial insurance plans, the drugmaker's CEO Daniel O'Day ...
Gilead stock toppled Thursday after CVS Health (CVS) said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results